Hyperlactatemia and in Utero Exposure to Antiretrovirals: Is the Control Group the Clue?SOLER-PALACIN, Pere; MARTIN-NALDA, Andrea; MARTINEZ-GOMEZ, Xavier et al.AIDS research and human retroviruses. 2012, Vol 28, Num 8, pp 752-758, issn 0889-2229, 7 p.Article

Effect of Antiretroviral Drugs on the Quality of SemenLAMBERT-NICLOT, Sidonie; POIROT, Catherine; FLANDRE, Philippe et al.Journal of medical virology. 2011, Vol 83, Num 8, pp 1391-1394, issn 0146-6615, 4 p.Article

Antiretroviral Treatment 2010: Progress and ControversiesGULICK, Roy M.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 55, issn 1525-4135, S43-S48, SUP1Article

Antiretroviral Activity of Ancestral TRIMSαGOLDSCHMIDT, Valérie; CIUFLI, Angela; ORTIZ, Millan et al.Journal of virology. 2008, Vol 82, Num 5, pp 2089-2096, issn 0022-538X, 8 p.Article

Identification of a Single Amino Acid Required for APOBEC3 Antiretroviral Cytidine Deaminase ActivityYING DANG; ABUDU, Aierken; SUNGMO SON et al.Journal of virology. 2011, Vol 85, Num 11, pp 5691-5695, issn 0022-538X, 5 p.Article

Application of a 3-Item Adherence Metric to Monitor Antiretroviral Medication Adherence in a Resource-Limited SettingAPISARNTHANARAK, Anucha; MUNDY, Linda M.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 55, Num 4, issn 1525-4135, p. 528Article

Interférences entre les traitements antirétroviraux, anti-VHC et immunosuppresseursPEYTAVIN, G.Médecine et maladies infectieuses. 2004, Vol 34, pp 20-21, issn 0399-077X, 2 p., HS2Conference Paper

Trends in Retention on Antiretroviral Therapy in National Programs in Low-Income and Middle-Income CountriesTASSIE, Jean-Michel; BAIJAL, Parijat; VITORIA, Marco A et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 54, Num 4, pp 437-441, issn 1525-4135, 5 p.Article

Antiretroviral Pharmacology in Mucosal TissuesTHOMPSON, Corbin G; COHEN, Myron S; KASHUBA, Angela D. M et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 63, issn 1525-4135, S240-S247, SUP2Article

Combination Antiretroviral Use and Preterm BirthWATTS, D. Heather; WILLIAMS, Paige L; KACANEK, Deborah et al.The Journal of infectious diseases. 2013, Vol 207, Num 4, pp 612-621, issn 0022-1899, 10 p.Article

Study on the interactions between anti-HIV-1 active compounds with trans-activation response RNA by affinity capillary electrophoresisLI DING; ZHANG, Xin-Xiang; CHANG, Wen-Bao et al.Journal of chromatography. B. 2005, Vol 814, Num 1, pp 99-104, issn 1570-0232, 6 p.Article

Directly Observed Antiretroviral Therapy in Substance Abusers Receiving Methadone Maintenance Therapy Does Not Cause Increased Drug ResistanceBRUST, James C. M; LITWIN, Alain H; BERG, Karina M et al.AIDS research and human retroviruses. 2011, Vol 27, Num 5, pp 535-541, issn 0889-2229, 7 p.Article

The Association Between Primary Antiretroviral Resistance and HAART Virologic Failure in a Developing SetHENRIQUE GAGLIANI, Luiz; ALKMIM MAIA, Wagner T; SA-FILHO, Dercy et al.AIDS research and human retroviruses. 2011, Vol 27, Num 3, pp 251-256, issn 0889-2229, 6 p.Article

Medium-Term Probability of Success of Antiretroviral Treatment after Early Warning Signs of Treatment Failure in West African AdultsDANEL, Christine; GABILLARD, Delphine; ANGLARET, Xavier et al.AIDS research and human retroviruses. 2009, Vol 25, Num 8, pp 783-793, issn 0889-2229, 11 p.Article

Quels bénéfices virologiques d'un traitement antirétroviral rapidement actif ?TARDY, J.-C.Médecine et maladies infectieuses. 2009, Vol 39, pp 1-4, issn 0399-077X, 4 p., HS2Conference Paper

Adult Clinical and Immunologic Outcomes of the National Antiretroviral Treatment Program in Rwanda During 2004-2005LOWRANCE, David W; NDAMAGE, Francois; RUKUNDO, Alphonse et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 52, Num 1, pp 49-55, issn 1525-4135, 7 p.Article

Short Communication: Three Years Follow-Up of First-Line Antiretroviral Therapy in Cambodia: Negative Impact of Prior Antiretroviral TreatmentSEGERAL, Olivier; LIMSRENG, Setha; OUK, Vara et al.AIDS research and human retroviruses. 2011, Vol 27, Num 6, pp 597-603, issn 0889-2229, 7 p.Article

Drug Interactions with New and Investigational AntiretroviralsBROWN, Kevin C; PAUL, Sunita; KASHUBA, Angela D. M et al.Clinical pharmacokinetics. 2009, Vol 48, Num 4, pp 211-241, issn 0312-5963, 31 p.Article

The Role of Toxicity-Related Regimen Changes in the Development of Antiretroviral ResistanceNEVIN, Christa R; YE, Jiatao; ABAN, Inmaculada et al.AIDS research and human retroviruses. 2011, Vol 27, Num 9, pp 957-963, issn 0889-2229, 7 p.Article

Tuberculosis in Antiretroviral Treatment Services in Resource-Limited Settings: Addressing the Challenges of Screening and DiagnosisLAWN, Stephen D; WOOD, Robin.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S1159-S1167, SUP4Article

Les dyslipoprotéinémies secondaires aux antirétrovirauxKEREKOU, A; CHADLI, A; EL GHOMARI, H et al.Espérance médicale. 2008, Vol 15, Num 153, 547-554 [6 p.]Article

Resistance to new anti-HIV agents : Problems in the pathway of drug registrationDALMAU, David; KLIMKAIT, Thomas; TELENTI, Amalio et al.Antiviral therapy (London). 2005, Vol 10, Num 7, pp 867-872, issn 1359-6535, 6 p.Article

Repeated Assessments of Food Security Predict CD4 Change in the Setting of Antiretroviral TherapyMCMAHON, James H; WANKE, Christine A; ELLIOTT, Julian H et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 58, Num 1, pp 60-63, issn 1525-4135, 4 p.Article

Evolution of Drug-Resistant Viral Populations during Interruption of Antiretroviral TherapyDONGNING WANG; HICKS, Charles B; GOSWAMI, Neela D et al.Journal of virology. 2011, Vol 85, Num 13, pp 6403-6415, issn 0022-538X, 13 p.Article

In Vivo Patterns of Resistance to the HIV Attachment Inhibitor BMS-488043NANNAN ZHOU; NOWICKA-SANS, Beata; KADOW, John et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 2, pp 729-737, issn 0066-4804, 9 p.Article